|
|
|
|
|
|
|
|
Center for Hyperthermia - Rhein Main
|
|
|
|
|
|
1. Center for Hyperthermia, Hessen
|
|
|
|
|
|
|
|
|
Regional Deep Hyperthermia (loco-regional Electro Hyperthermia) and modern Oncology - |
|
|
the ideal combination of Conventional Medicine and integrative Oncology. |
|
|
|
|
|
|
|
|
The term Hyperthermia refers to the process of heating-up tumor tissue with the objective to |
|
|
destroy tumor cells |
|
|
|
|
|
The hyperthermal overheating process at temperatures over 104.0° F (40°C) result -among other things- in: |
|
|
|
|
|
- damage of the tumor cell membrane |
|
|
- hyperacidity of cancer cells (increase of responsiveness to chemo- and |
|
radiation therapy) |
|
- generation of heat shock proteins on the surface of cancer cells |
|
|
(identification enhancement of cancer cells as foreign cells) |
|
|
|
|
|
|
|
|
Most important Hyperthermia methods - (Oncothermia) |
|
|
Mastall, H. "Mit Hyperthermie Krebs wirksam bekämpfen." (How to Effectively Fight Cancer with Hyperthermia) Naturarzt 2004;12:11-12 (1.Version) |
|
|
|
|
|
*Whole-body Hyperthermia (extreme up to 107.6°F (42°C)) |
|
|
(complex, mainly performed in hospitals, requires intensive medical monitoring) |
|
|
|
|
|
*Whole-body Hyperthermia (moderate from 102.2° to 104.0°F (39° to 40°C) |
|
|
(particulary for the stimulation of the immune system) |
|
|
|
|
|
*Superficial Hyperthermia |
|
|
(applicable with superficial skin tumors) |
|
|
|
|
|
*Intracavitary Perfusions - Hyperthermia |
|
|
(with inoperable abdominal tumors) |
|
|
|
|
|
*Prostate - Hyperthermia |
|
|
(with prostate cancer) |
|
|
|
|
|
|
|
|
*Regional Deep Hyperthermia (Loco-regional Electro Hyperthermia) |
|
|
(outpatient therapy of locally confined tumors and metastases) |
|
|
|
|
|
Mastall, H. "Mit Hyperthermie Krebs wirksam bekämpfen." (How to Effectively Fight Cancer with Hyperthermia). Naturarzt 2004;12:11-12 |
|
|
|
|
|
Mastall H. "Lebensrettendes Wissen bei der Diagnose Krebs." (Life-saving Knowledge for Cancer Diagnosis). FEM 1997; 5:13-16 |
|
|
|
|
|
|
|
|
Regional deep Hyperthermia is an important treatment in advanced |
|
|
biological cancer therapy ( i.e. Integrative Oncology = Complementary Oncology) |
|
|
|
|
|
Regional deep Hyperthermia indications: |
|
|
|
|
|
all locally confined tumors/metastases for which surgery is no option |
|
|
- in combination with radiation therapy |
|
|
- in combination with systemic or regional chemotherapy |
|
|
- in combination with radiation- and chemotherapy |
|
|
- in combination with immunotherapy, monoclonal antibody therapy or |
|
|
hormones |
|
|
- Monotherapy, if chemotherapy is no option. |
|
|
|
|
|
Leading oncological clinics in Italy use
|
|
|
Synchro-thermal hyperthermia devices for regional deep hyperthermia. |
|
|
|
|
|
In Germany, one of the few synchro-thermal hyperthermia devices is actually used |
|
|
1. in the Juvital Hyperthermia Medical Center in Hessen.
|
|
|
|
|
|
|
|
|
Advantages of the SYNCHRO-THERMAL hyperthermia devices: |
. |
|
|
|
|
1. |
flexibly malleable water-cooled energy radiators |
|
|
|
|
|
|
2. |
that adapt to the treated body parts (e.g. head, breast, abdomen) |
|
|
|
|
|
|
Deep Hyperthermia has 2 courses of treatment: |
|
|
|
|
|
First, zhere are 15 one-hour treatments for the course of 5 weeks, |
|
|
that is 3 treatments per week; |
|
|
|
|
|
then, a second course of 10 to 12 one-hour treatments |
|
|
following a therapy-free period. |
|
|
|
|
|
There has to be a 1 to 2 day break between the treatments, to be able to take |
|
|
the detected tumor cell thermotolerance (adaption to heat) into account. |
|
|
|
|
|
Thus, 2 to 3 treatments are possible within the course of one week. |
|
|
|
|
|
|
|
|
Regional Deep Hyperthermia |
|
|
|
|
|
Positive treatment outcomes through Regional Deep Hyperthermia could be |
|
|
seen in: |
|
|
|
|
|
Lung tumors, esp. Pleural mesothelioma |
|
|
Liver tumors |
|
|
Pancreatic cancer |
|
|
Stomach, colorectal, rectum cancer |
|
|
Bladder Cancer |
|
|
Gynaecological tumors: breast cancer, ovarial cancer, uterine cancer, |
|
|
vaginal cancer |
|
|
Tumors in the ear, nose and throat region, oesophagal cancer |
|
|
Sarcoma |
|
|
Brain tumors |
|
|
Bone metastases |
|
|
|
|
|
|
|
|
SIDE EFFECTS OF THE LOCO-REGIONAL ELECTRO-HYPERTHERMIA: |
|
|
|
|
|
|
* |
Erythema of the treated part (rare) |
|
|
* |
Fatigue |
|
|
* |
Due to the intensified amount of dying malignant cells, |
|
|
|
a mild fever might occur in the days following the treatment. (Whole-body heating of 3.6°F (2°C) desirable for |
|
|
|
immune stimulation) |
|
|
|
|
|
|
Contraindications of loco-regional Electro Hyperthermia: |
|
|
|
|
|
|
* |
Cardiac pacemakersand other types of pacemaker electrodes. In this case the operating |
|
|
|
frequencies might be altered and cause malfunctions. |
|
|
|
|
|
|
* |
Joint replacements may act as antennas, heat up, and lead to |
|
|
|
burns, but only if metal is present in the area to-be-treated. |
|
|
|
|
|
|
|
|
|
|
Goals of Regional Deep Hyperthermia: |
|
|
|
|
|
A: Tumor or (progressing) metastases growth prevention |
|
|
B: Tumor reduction, if possible to operable sizes (partial remission) |
|
|
C: Tumor disappearance (complete remission) |
|
|
D: Radiation and/or chemotherapy efficacy improvement |
|
|
E: Reduction of resistance development to chemotherapeutics or reintroduction of |
|
|
chemotherapeutics sensitivity |
|
|
|
|
|
Liver metastases before RTH - Liver metastases after RTH
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liver metastases with breast cancer |
|
|
Progressive liver metastases in metastatic breast cancer (Ed.1/96 ) receiving systemic chemotherapy treatment (4xEC). After six 1-hour long Regional Deep Hyperthermia treatments with chemotherapy continuation, a partial remission of 80% was achieved; Source: |
|
|
|
|
|
Mastall H. "Zeit- und situationsgerechte Einsatzmodelle für komplementäre Verfahren während |
|
|
konventionell-onkologischer Therapien" (Modern and Situation-oriented Deployment Models for Complementary Medicine during Conventional Oncology Therapies) |
|
|
32. Medizinische Woche Baden-Baden 1998; 02.XI |
|
|
|
|
|
Lung metastases before RTH - lung metastases after RTH
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lung cancer
|
|
|
diffuse lung metastasis of a mucinous adenocarcinoma of unknown origin (CUP-syndrome) Ed. 1/97. 2 treatments of regional chemotherapy in combination with 12 treatments of Regional Deep Hyperthermia (3x per week) resulted in complete remission; Source: |
|
|
|
|
|
Mastall H. "Zeit- und situationsgerechte Einsatzmodelle für komplementäre Verfahren während |
|
|
konventionell-onkologischer Therapien" (Modern and Situation-oriented Deployment Models for Complementary Medicine during Conventional Oncology Therapies). |
|
|
32. Medizinische Woche Baden-Baden 1998; 02.XI |
|
|
|
|
|
Lung metastases before surgery
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lung metastasis of colonrectal cancer (ED 11/97). Two lung metastasis treatments with Regional Deep Hyperthermia before surgery. |
|
|
Result: |
|
|
The postoperative reconstruction of the tumor showed a 70% necrosis (cell death) of the |
|
|
lung metastasis; Source: |
|
|
|
|
|
Mastall H. "Zeit- und situationsgerechte Einsatzmodelle für komplementäre Verfahren während |
|
|
konventionell-onkologischer Therapien" (Modern and Situation-oriented Deployment Models for Complementary Medicine Methods during Conventional Oncology Therapies). |
|
|
32. Medizinische Woche Baden-Baden 1998; 02.XI |
|
|
|
|
|
Statement regarding Regional Deep Hyperthermia by MD. SAHIMBAS |
|
|
Grönemeyer Institute |
|
|
Ruhr University |
|
|
Bochum |
|
|
|
|
|
"There are no inoperable tumors or metastases where
|
|
|
Regional Deep Hyperthermia may not be performed"
|
|
|
|
|
|
|
|
|
|
|
|
Statement by |
|
|
Prof. Dr. Anchras Szasz |
|
|
Biotechnics Department |
|
|
St. Istvan University, Hungary |
|
|
Hyperthermie Symposium, 22 + 23/SEP/06, Cologne: |
|
|
|
|
|
"The Regional Deep Hyperthermia shows an extremely low risk, while offering
|
|
|
an extremely high benefit to the patients
|
|
|
with an excellent cost-benefit-ratio."
|
|
|
|
|
|
|
|
| |
|
|